Trinity Delta are the healthcare and life sciences specialists.We provide the highest quality services and insights to small/mid-cap healthcare and life sciences companies, and to investors. Our core focus is institutional quality issuer-paid research in the biotech, medtech, speciality pharma, and consumer health sectors. Our goal is to bring exciting investment ideas to investors, and to assist companies in achieving their objectives.Under MiFID II, whether you are an asset manager or a private investor, all can continue to receive Trinity Delta research notes. Our research is paid for by our corporate clients and we do not carry out any execution business. We do and will continue to make it freely available to all investors via multiple platforms (see trinitydelta.org).We also firmly believe that by putting our clients first, we create long term value for all stakeholders.